THE LIVINGSTON GROUP, LLC

Lobbying for INNOVATIVE VACCINE TECHNOLOGIES · Bio tech company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Utah · posted Oct 14, 2025

Lobbying activity 2

Medical/Disease Research/Clinical Labs

FY2026 appropriations for the development of a synthetic vaccine

Budget/Appropriations

FY2026 appropriations for the development of a synthetic vaccine

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.